Answer
Verdict
Not enough evidence
Stopping a GLP-1 drug commonly leads to weight regain.
2 sources: 2 positive
By Arun AgrahriLast reviewed 1 timecoded source
Short answer
Most people regain weight. In the STEP 1 trial, two-thirds of people regained the weight they lost within two years of stopping semaglutide. The bigger risk: you can regain fat without the muscle you lost, leaving worse body composition than you started. Habits built while on the drug improve your odds of holding the loss.
GLP-1 drugs are worth taking for people with obesity.
The verdict on GLP-1 Agonists overall. 18 sources: 6 positive, 9 partly, 3 negative
positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.
Stopping a GLP-1 drug commonly leads to weight regain.
2 sources: 2 positive. Fewer than 3 sources so far.
Researchers say
1 positive
Peter Attia, on The Drive, at 01:44
Positive Video · Opinion
Open the tape at 01:44 →“most people are going to regain weight once they stop taking the”
Studies show
1 positive
1 cited on tape, not yet checked against the paper
STEP 1, cited on The Dr. Hyman Show, at 24:19
Positive Study
Open the tape at 24:19 →“in this one study called the step one trial semaglutide treatment effect in people with obesity it was a randomized control trial where they found that uh two-thirds of people regain the weight they lost two years after discontinuing”
Peter Attia, on The Drive, at 01:44 Video · positive · Opinion
“most people are going to regain weight once they stop taking the”
STEP 1, cited on The Dr. Hyman Show, at 24:19 Study · positive
“in this one study called the step one trial semaglutide treatment effect in people with obesity it was a randomized control trial where they found that uh two-thirds of people regain the weight they lost two years after discontinuing”
Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent
1 update since September 2026. Each one is a dated statement on the record, timecoded to the video.
Half are off it within a year, and he calls it a drug for life
A Harvard interventional gastroenterologist puts numbers on the stopping problem, about 30 percent off in the first month and around half by the end of the year. He treats these as lifelong drugs, says regained weight comes back as fat rather than muscle, and has many patients step down to a micro dose instead of quitting. Others prefer a steady lower dose or low-dose cycling with a planned exit, and one calls lifelong use the problem.
on the record @ 30:21Nobody has answered
Whether tapering to a micro dose holds the loss better than stopping outright. The record agrees regain is the default when people stop and disagrees about what to do with that. Thompson adds that he knows of no study that made resistance training on these drugs the main outcome, even though he and Knight both lean on it to protect muscle.
Stopping a GLP-1 drug commonly leads to weight regain. Mark Hyman, on his own show, cites the STEP 1 trial, a randomized trial of semaglutide in people with obesity. Two-thirds of people regained the weight they lost within two years of stopping.
Peter Attia says these drugs are best used indefinitely, because appetite and food noise return to baseline once the drug clears. Ralph DeFronzo, a guest on Attia's show, confirms high relapse rates after stopping. He notes that many people stop within a year anyway because of cost (around $1,000/month) and side effects.
Chris Thompson, a guest on Andrew Huberman's show, calls them lifelong medicines that are not meant to be stopped.
If you lost muscle on the way down and then regain fat without that muscle, you can end up with worse body composition than you started. Ben Bikman makes that point as a guest on The Diary of a CEO. It is the strongest argument for defending muscle hard while you are on the drug.
Some clinicians think so. Bikman frames microdosing plus behavioral coaching as a roughly 90-day tool to rewire cravings so you can taper off. Slow, steady dosing beats on-and-off "yo-yo" cycling.
Attia's practical version is to use your time on the drug to build the habits that give you a chance of holding the loss: protein, training, sleep and food quality.
Hyman reads the high regain rate as the core problem. A drug that has to be taken forever, he argues, masks the root cause rather than fixing it.
Precis membership
The answer above is the whole answer: the verdict, every counted mention, where the sources disagree, and the receipt behind each one. Nothing on this page is held back.
A free account adds
Pro adds
Full GLP-1 Agonists evidence report
The verdict on every claim, and where the sources disagree